D

Delcath Systems
D

DCTH

8.21000
USD
-0.43
(-4.98%)
Market Closed
Volume
6,188
EPS
0
Div Yield
0
P/E
-4
Market Cap
305,489,197
OverviewSignalsIdeasNews
Related Instruments
    A
    ABEO
    -0.10000
    (-2.04%)
    4.80000 USD
    A
    AEZS
    0.14000
    (2.41%)
    5.94000 USD
    A
    ARDX
    -0.02500
    (-0.45%)
    5.52500 USD
    B
    BLPH
    0
    (0%)
    0.000000 USD
    C
    CAPR
    -0.17000
    (-4.19%)
    3.89000 USD
    C
    CDTX
    -0.190
    (-1.45%)
    12.890 USD
    C
    CLRB
    -0.10000
    (-4.65%)
    2.05000 USD
    E
    EDIT
    -0.28500
    (-5.26%)
    5.13500 USD
    X
    XENE
    0.630
    (1.46%)
    43.790 USD
News

Title: Delcath Systems

Sector: Healthcare
Industry: Medical Devices
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS,is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.